Neuron-Specific Alterations in Signal Transduction Pathways associated with Alzheimer's Disease

被引:27
|
作者
Gerschuetz, Anne [1 ]
Heinsen, Helmut [2 ]
Gruenblatt, Edna [3 ]
Wagner, Anne Kristin [1 ]
Bartl, Jasmin [3 ]
Meissner, Christoph [4 ]
Fallgatter, Andreas J. [5 ]
Al-Sarraj, Safa [6 ]
Troakes, Claire [6 ]
Ferrer, Isidro [7 ]
Arzberger, Thomas [8 ]
Deckert, Juergen [2 ]
Riederer, Peter [2 ]
Fischer, Matthias [2 ]
Tatschner, Thomas [9 ]
Monoranu, Camelia Maria [1 ]
机构
[1] Univ Wurzburg, Dept Neuropathol, Inst Pathol, D-97080 Wurzburg, Germany
[2] Univ Wurzburg, Univ Hosp, Clin & Policlin Psychiat Psychosomat & Psychother, D-97080 Wurzburg, Germany
[3] Univ Zurich, Clin Child & Adolescent Psychiat, Zurich, Switzerland
[4] Univ Schleswig Holstein, Dept Forens Med, Lubeck, Germany
[5] Univ Tubingen, Clin & Policlin Psychiat & Psychotherapy, Tubingen, Germany
[6] Kings Coll London, MRC London Neurodegenerat Dis Brain Bank, London, England
[7] IDIBELL Hosp Univ Bellvitge, Serv Anat Patol, Inst Neuropatol, Barcelona, Spain
[8] Univ Munich, Inst Neuropathol & Prion Res, Munich, Germany
[9] Univ Wurzburg, Inst Legal Med, D-97070 Wurzburg, Germany
关键词
Alzheimer's disease; MAPK1; neurodegeneration; PRKCB; selective vulnerability; signal transduction pathway; PROTEIN-KINASE-C; VAGUS NERVE-STIMULATION; FAR-FIELD POTENTIALS; BRAIN-STEM; NEUROFIBRILLARY DEGENERATION; HIPPOCAMPAL-FORMATION; PYRAMIDAL NEURON; MESSENGER-RNA; TAU-PROTEIN; CELLS;
D O I
10.3233/JAD-131280
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The hallmarks of sporadic Alzheimer's disease (AD) are extracellular amyloid deposits, intracellular neurofibrillary tangles (NFTs), and neuronal death. Hyperphosphorylation of tau is a key factor in the generation of NFTs. Mitogen activated protein kinase 1 (MAPK1) and protein kinase C beta (PRKCB) are thought to play a role in hyperphosphorylation, and PRCKB is thought to be involved in hypoxic stress and vascular dysfunction, and to trigger MAPK phosphorylation pathways. We performed single-cell analyses of neurons with different vulnerabilities to AD-related changes. Using quantitative PCR (qPCR), we measured the levels of MAPK1 and PRKCB transcript in CA1 (high vulnerability), CA2 pyramidal cells from the hippocampus, granule cells from the cerebellum (low vulnerability), and neurons from the brain stem (nucleus tractus spinalis nervi trigemini, characterized by early neurophysiological deficits) at progressive Braak stages compared to age-matched controls. The highly vulnerable CA1 pyramidal neurons were characterized by age-and disease-unrelated increases in PRCKB levels and by age-and disease-related increases in MAPK1 levels. In contrast, low PRKCB levels were found in CA2 pyramidal neurons, and MAPK1 levels were elevated in controls and intermediate AD stages. Both PRKCB and MAPK1 were increased in the late AD stages. MAPK1 and PRKCB levels were low in the brainstem and cerebellum. We propose that alterations in the expression of these two genes occur early in the pathogenesis of AD in a region-specific manner. In addition, multiple signal transduction pathways need to be affected to result in AD instead of physiological aging.
引用
收藏
页码:135 / 142
页数:8
相关论文
共 50 条
  • [1] Neuron-specific histone modification analysis of Alzheimer's disease brains
    Mano, Kagari
    Mano, Tatsuo
    Iwata, Atsushi
    Murayama, Shigeo
    Toda, Tatsushi
    BRAIN PATHOLOGY, 2019, 29 : 71 - 71
  • [2] Exploring neuron-specific steroid synthesis and DHEAS therapy in Alzheimer's disease
    Lin, Hong-Yi
    Feng, Yin-Hsun
    Kao, Tzu-Jen
    Chen, Hsien-Chung
    Chen, Guan-Yuan
    Ko, Chiung-Yuan
    Hsu, Tsung-I.
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2024, 243
  • [3] Alzheimer's disease β-secretase BACE1 is not a neuron-specific enzyme
    Rossner, S
    Lange-Dohna, C
    Zeitschel, U
    Perez-Polo, JR
    JOURNAL OF NEUROCHEMISTRY, 2005, 92 (02) : 226 - 234
  • [4] Neuron-Specific Mitochondrial DNA Deletion Levels in Sporadic Alzheimer's Disease
    Gerschuetz, Anne
    Heinsen, Helmut
    Gruenblatt, Edna
    Wagner, Anne K.
    Bartl, Jasmin
    Meissner, Christoph
    Fallgatter, Andreas J.
    Al-Sarraj, Safa
    Troakes, Claire
    Ferrer, Isidro
    Arzberger, Thomas
    Deckert, Juergen
    Riederer, Peter
    Fischer, Matthias
    Tatschner, Thomas
    Monoranu, Camelia M.
    CURRENT ALZHEIMER RESEARCH, 2013, 10 (10) : 1041 - 1046
  • [5] Cerebrospinal fluid neuron-specific enolase: a further marker of Alzheimer's disease?
    Palumbo, Barbara
    Siepi, Donatella
    Sabalich, Isabella
    Tranfaglia, Cristina
    Parnetti, Lucilla
    FUNCTIONAL NEUROLOGY, 2008, 23 (02) : 93 - 96
  • [6] The Alzheimer's disease β-secretase (BACE1) is not a neuron-specific enzyme
    Rossner, S
    Hartlage-Rübsamen, M
    Lange-Dohna, C
    Zeitschel, U
    Bigl, V
    JOURNAL OF NEUROCHEMISTRY, 2003, 85 : 98 - 98
  • [7] Signal transduction in Alzheimer's disease
    Smith, MA
    Zhu, XW
    Perry, G
    NEUROSIGNALS, 2002, 11 (05) : 235 - 235
  • [8] Brain Gangliosides in Alzheimer's Disease: Increased Expression of Cholinergic Neuron-Specific Gangliosides
    Fukami, Yuki
    Ariga, Toshio
    Yamada, Mitsunori
    Yuki, Nobuhiro
    CURRENT ALZHEIMER RESEARCH, 2017, 14 (06) : 586 - 591
  • [9] Brain gangliosides in Alzheimer's disease: Increased expression of cholinergic neuron-specific gangliosides
    Fukami, Y.
    Ariga, T.
    Yamada, M.
    Yuki, N.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 326 - 326
  • [10] Neuron-specific localisation of the TR3 death receptor in Alzheimer's disease
    Maycox, PR
    Bond, B
    Crook, B
    Darker, J
    Edge, C
    Newman, SJ
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2000, 12 : 110 - 110